ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Study Tests Method For Biomarker Validation

July 24, 2009

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

ACOR Opens Cancer-pain.org

March 2, 2001

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001

In Brief: ACCC Annual Meeting Scheduled March 16-19; Lao to Head Pharmacology At Pittsburgh

January 1, 1988